DoD Multiple Sclerosis, Early Investigator Research Award | W81XWH 22 MSRP EIRA

Opportunity Information: Apply for W81XWH 22 MSRP EIRA

The Department of Defense (DoD), through the Department of the Army and the U.S. Army Medical Research Acquisition Activity (USAMRAA), offered the Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award (EIRA) under Funding Opportunity Number W81XWH 22 MSRP EIRA. This opportunity is designed specifically to build and strengthen the next generation of multiple sclerosis (MS) researchers by supporting MS-focused projects led by investigators who are still in the early stages of their careers. The core idea is career development through doing real MS research: the award is meant to help an early investigator shape and carry out an independent research project, explore a focused scientific question or problem relevant to MS, and grow intellectually and professionally into a future leader in the field.

A defining feature of this award is the structured mentorship requirement. Applicants are expected to conduct the proposed research under the guidance of one or more designated mentors, which signals that the program values both scientific progress and deliberate training. Even with mentor involvement, the funding notice emphasizes that the Principal Investigator (PI) should be the primary author of all application components. In other words, the early-career applicant is expected to drive the proposal, articulate the research plan, and demonstrate ownership of the project, while mentors provide direction and support rather than writing the application on the PI's behalf.

From an administrative standpoint, the opportunity is classified as a discretionary federal assistance program in the science and technology/research and development area (CFDA number 12.420). The funding instrument types listed include both grants and cooperative agreements, indicating that awards could be structured either as more traditional grant funding or as cooperative agreements where the government may have a more active role in oversight or collaboration, depending on the specific terms of the award. The listing notes an expected total of six awards. The posted award ceiling is shown as 0, which typically indicates that the maximum award amount was not specified in the summary fields provided here (often the detailed funding announcement or program announcement contains budget limits, caps, or guidance that is not captured in the abbreviated metadata).

Eligibility is described as "unrestricted," meaning it is broadly open to applicants across entity types, subject to any clarifications that might appear in the full text under "Additional Information on Eligibility." In practice, language like this generally suggests that a wide range of organizations may apply (for example, universities, research institutes, hospitals, companies, or nonprofits), so long as they meet the program's stated requirements and any standard federal assistance eligibility rules. The opportunity was created on April 29, 2022, and the original application deadline was October 3, 2022, placing it within the FY22 cycle of the DoD MSRP.

Overall, the DoD MSRP Early Investigator Research Award is best understood as a mentored, early-career development mechanism tied to a concrete MS research project. It is aimed at helping new investigators establish themselves by proposing and executing MS-relevant research while receiving structured guidance, with the expectation that the PI takes clear intellectual ownership of the application and the work.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Multiple Sclerosis, Early Investigator Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 29, 2022.
• Applicants must submit their applications by Oct 03, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 6 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 MSRP EIRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: